Otsuka Pharmaceutical Co., Ltd.
Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd., explained in plain language.
-
Experimental cocktail aims to tackle tough lymphoma
Disease control CompletedThis early-phase trial tested an experimental drug called OPB-111077 combined with two standard chemotherapy drugs (bendamustine and rituximab) in 36 people whose diffuse large B-cell lymphoma had come back or stopped responding to treatment. The main goal was to check the safety…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for high cholesterol: Statin-Free drug shows promise in Year-Long study
Disease control CompletedThis study tested a daily pill called ETC-1002 in 130 adults with very high LDL ("bad") cholesterol who either didn't respond well to statins or had side effects from them. Over 52 weeks, researchers checked how safe the drug was and how much it lowered cholesterol. The goal was …
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Does food change how schizophrenia drug works? new study answers
Disease control CompletedThis study looked at whether taking a new once-weekly schizophrenia medication with food changes how much of the drug gets into the blood. Fifty-nine adults with stable schizophrenia took the drug once with food and once without food. The goal was to see if food affects drug leve…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Kidney drug tolvaptan put to the test in Real-World japanese patients
Disease control CompletedThis study followed 1802 Japanese patients with autosomal dominant polycystic kidney disease (ADPKD) who were taking tolvaptan in real-world clinics. Researchers tracked safety and how well the drug slowed kidney growth. The goal was to see if tolvaptan works as well outside cont…
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill aims to drain fluid in stubborn heart failure swelling
Symptom relief CompletedThis study tested an experimental drug called OPC-131461 in 157 people with congestive heart failure who still had fluid buildup despite taking standard water pills. Participants received different doses of the drug or a placebo daily for 14 days. The main goal was to see if the …
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC